Envestnet Asset Management Inc Atara Biotherapeutics, Inc. Transaction History

Envestnet Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.23 - $1.74 $3,711 - $28,078	-16,137 Reduced 36.89%	27,612 $14,000
Q3 2023 Nov 13, 2023	BUY	$1.41 - $2.31 $19,971 - $32,718	14,164 Added 47.88%	43,749 $64,000
Q2 2023 Aug 04, 2023	SELL	$1.5 - $3.04 $3,363 - $6,815	-2,242 Reduced 7.04%	29,585 $47,000
Q1 2023 May 11, 2023	BUY	$2.8 - $5.46 $49,058 - $95,664	17,521 Added 122.47%	31,827 $92,000
Q4 2022 Feb 07, 2023	SELL	$2.85 - $5.18 $4,956 - $9,008	-1,739 Reduced 10.84%	14,306 $46,000
Q3 2022 Nov 10, 2022	BUY	$2.85 - $8.73 $15,928 - $48,791	5,589 Added 53.45%	16,045 $61,000
Q2 2022 Aug 03, 2022	SELL	$4.69 - $9.84 $7,452 - $15,635	-1,589 Reduced 13.19%	10,456 $81,000
Q1 2022 May 04, 2022	BUY	$8.44 - $16.89 $101,659 - $203,440	12,045 New	12,045 $112,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $68,838 - $85,434	-1,964 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$35.15 - $51.45 $9,244 - $13,531	263 Added 15.46%	1,964 $72,000
Q1 2018 May 09, 2018	BUY	$18.0 - $48.35 $12,420 - $33,361	690 Added 68.25%	1,701 $66,000
Q4 2017 Feb 20, 2018	SELL	$13.2 - $18.1 $5,847 - $8,018	-443 Reduced 30.47%	1,011 $18,000
Q3 2017 Nov 13, 2017	BUY	$13.25 - $17.05 $1,033 - $1,329	78 Added 5.67%	1,454 $24,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,376	1,376 $19,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.25B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.